Summary:The diagnosis of venous insufficiency is increasing. Multiple techniques are available for its treatment. Chemical sclerotherapy has been performed for over 70 years. The technique improves lately. Objective: This study was conducted to assess early results of foam sclerotherapy in Senegal. Patients and Methods: This is a prospective and descriptive study conducted from January 1st, 2012 to December 31st, 2015 at cardiovascular center of Fann University hospital in Dakar, Senegal. Foam sclerotherapy was done in 76 patients. Polidocanol was used in concentration of 2%. Sclerotherapy was done several times in patients, every week, as much as needed to occlude varicose veins. We used venous compression in all patients. Results: Foam sclerotherapy sessions permitted to get globally good results. In fact, tight feeling and painful leg disappear in 97% of patients. Decreases of edema were gotten in 97% of patients. For leg ulcer, 64% of complete healing was obtained. The main ulcer healing time was 47 days (18; 72).Some minor complications occurred. No major events, such as deep venous thrombosis or pulmonary embolism, were observed. Conclusion: Foam sclerotherapy is an efficient technique for the treatment of varicose veins of the limbs. Also, it opens good perspectives for vein care.
References
[1]
Dieng, P.A., Diatta, S., Ba, P.S., Touré, F.B., Ciss, A.G., Gaye, M., Fall, M.L., Diarra, O. and Ndiaye, M. (2014) Traitement chirurgical des varices des membres inférieurs a Dakar: étude rétrospective de 91 cas. Journal Africain de Chirurgie, 3, 23-27.
Guex, J.J. (2005) Foam Sclerotherapy: An Overview of Use for Primary Venous Insufficiency. Seminars in Vascular Surgery, 18, 25-29.
https://doi.org/10.1053/j.semvascsurg.2004.12.008
[4]
Eckmann, D.M., Kobayashi, S. and Li, M. (2005) Microvascular Embolization Following Polidocanol Microfoam Sclerosant Administration. Dermatologic Surgery, 31, 636-643. https://doi.org/10.1097/00042728-200506000-00004
[5]
Parsi, K., Exner, T., Connor, D.E., et al. (2008) The Lytic Effects of Detergent Sclerosants on Erythrocytes, Platelets, Endothelial Cells and Microparticles Are Attenuated by Albumin and Other Plasma Components in Vitro. European Journal of Vascular and Endovascular Surgery, 36, 216-223.
https://doi.org/10.1016/j.ejvs.2008.03.001
[6]
Rabe, E., Otto, J., Schliephake, D. and Pannier, F. (2008) Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): A Randomised Controlled Multicentre Clinical Trial. European Journal of Vascular and Endovascular Surgery, 35, 238-245. https://doi.org/10.1016/j.ejvs.2007.09.006
[7]
Davis, L.T. and Duffy, D.M. (1990) Determination of Incidence and Risk-Factors for Postsclerotherapy Telangiectatic Matting of the Lower-Extremity—A Retrospective Analysis. Journal of Dermatologic Surgery and Oncology, 16, 327-330.
https://doi.org/10.1111/j.1524-4725.1990.tb00043.x
[8]
Rasmussen, L.H., Lawaetz, M., Bjoern, L., et al. (2011) Randomized Clinical Trial Comparing Endovenous Laser Ablation, Radiofrequency Ablation, Foam Sclerotherapy and Surgical Stripping for Great Saphenous Varicose Veins. British Journal of Surgery, 98, 1079-1087. https://doi.org/10.1002/bjs.7555
[9]
Myers, K.A., Jolly, D., Clough, A. and Kirwan, J. (2007) Outcome of Ultrasound-Guided Sclerotherapy for Varicose Veins: Medium-Term Results Assessed by Ultrasound Surveillance. European Journal of Vascular and Endovascular Surgery, 33, 116-121.
https://doi.org/10.1016/j.ejvs.2006.09.005
[10]
Hamel-Desnos, C., Ouvry, P., Benigni, J.P., Boitelle, G., Shadeck, M., Desnos, P., et al. (2007) Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-Blind Trial with 2 Year Follow-Up. European Journal of Vascular and Endovascular Surgery, 34, 723-729. https://doi.org/10.1016/j.ejvs.2007.07.014
